Literature DB >> 33270220

CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress.

J M Meyer1, E Lee1, A Celli1, K Park1, R Cho2, W Lambert3, M Pitchford1, M Gordon1, K Tsai4, J Cleaver5, S T Arron1, T M Mauro1.   

Abstract

BACKGROUND: Ceramide Kinase-Like Protein (CERKL) was originally described in retinal tissue. CERKL has been shown to protect cells from oxidative stress, and mutations in CERKL underlie the inherited disease, retinitis pigmentosa. CERKL expression maintains cellular sphingolipids via an unknown mechanism.
OBJECTIVES: To determine whether CERKL is expressed in epidermis and cutaneous squamous cell carcinoma (cSCC) and whether CERKL expression affects cSCC sphingolipid metabolism and susceptibility to oxidative stress.
METHODS: CERKL expression was determined by RNA-Seq, qPCR and immunohistochemistry. CERKL was knocked down in cSCC cells using siRNA. Sphingolipid content was analyzed by liquid chromatography-mass spectrometry (LC-MS). Oxidative stress was induced by treatment with H2 O2 , and apoptosis was measured using flow cytometry to determine annexin v binding.
RESULTS: CERKL mRNA and protein are highly expressed in actinic keratosis and cSCC in comparison with normal epidermis. CERKL also is expressed in metabolically active epithelial cells in normal hair bulbs and sebaceous glands. CERKL knockdown in cultured cSCC cells reduces cellular sphingolipid content and enhances susceptibility to oxidative stress.
CONCLUSIONS: These findings suggest that CERKL may be important in cSCC progression and could lead to novel strategies for prevention and treatment of cSCC. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2020        PMID: 33270220      PMCID: PMC8172666          DOI: 10.1111/bjd.19707

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   11.113


  20 in total

Review 1.  Cancer, Oxidative Stress, and Metastasis.

Authors:  Jennifer G Gill; Elena Piskounova; Sean J Morrison
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2017-01-12

2.  Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26).

Authors:  Miquel Tuson; Gemma Marfany; Roser Gonzàlez-Duarte
Journal:  Am J Hum Genet       Date:  2003-12-16       Impact factor: 11.025

3.  Diagnosing xeroderma pigmentosum group C by immunohistochemistry.

Authors:  Sébastien de Feraudy; Imenne Boubakour-Azzouz; Sylvie Fraitag; Mark Berneburg; Loretta Chan; Kevin Chew; Carol L Clericuzio; Bari Cunningham; Whitney D Tope; James E Cleaver
Journal:  Am J Dermatopathol       Date:  2010-04       Impact factor: 1.533

4.  ROS Promotes Cancer Cell Survival through Calcium Signaling.

Authors:  Colleen R Reczek; Navdeep S Chandel
Journal:  Cancer Cell       Date:  2018-06-11       Impact factor: 31.743

5.  Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice.

Authors:  Christine Graf; Satoru Niwa; Matthias Müller; Bernd Kinzel; Frédéric Bornancin
Journal:  Biochem Biophys Res Commun       Date:  2008-06-12       Impact factor: 3.575

Review 6.  Sphingolipids as Regulators of Autophagy and Endocytic Trafficking.

Authors:  Megan M Young; Hong-Gang Wang
Journal:  Adv Cancer Res       Date:  2018-05-22       Impact factor: 6.242

7.  SERCA2-controlled Ca²+-dependent keratinocyte adhesion and differentiation is mediated via the sphingolipid pathway: a therapeutic target for Darier's disease.

Authors:  Anna Celli; Donald S Mackenzie; Yongjiao Zhai; Chia-Ling Tu; Daniel D Bikle; Walter M Holleran; Yoshikazu Uchida; Theodora M Mauro
Journal:  J Invest Dermatol       Date:  2012-01-26       Impact factor: 8.551

8.  CERKL knockdown causes retinal degeneration in zebrafish.

Authors:  Marina Riera; Demian Burguera; Jordi Garcia-Fernàndez; Roser Gonzàlez-Duarte
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

9.  Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.

Authors:  Vida Chitsazzadeh; Cristian Coarfa; Jennifer A Drummond; Tri Nguyen; Aaron Joseph; Suneel Chilukuri; Elizabeth Charpiot; Charles H Adelmann; Grace Ching; Tran N Nguyen; Courtney Nicholas; Valencia D Thomas; Michael Migden; Deborah MacFarlane; Erika Thompson; Jianjun Shen; Yoko Takata; Kayla McNiece; Maxim A Polansky; Hussein A Abbas; Kimal Rajapakshe; Adam Gower; Avrum Spira; Kyle R Covington; Weimin Xiao; Preethi Gunaratne; Curtis Pickering; Mitchell Frederick; Jeffrey N Myers; Li Shen; Hui Yao; Xiaoping Su; Ronald P Rapini; David A Wheeler; Ernest T Hawk; Elsa R Flores; Kenneth Y Tsai
Journal:  Nat Commun       Date:  2016-08-30       Impact factor: 14.919

10.  CERKL regulates autophagy via the NAD-dependent deacetylase SIRT1.

Authors:  Xuebin Hu; Zhaojing Lu; Shanshan Yu; James Reilly; Fei Liu; Danna Jia; Yayun Qin; Shanshan Han; Xiliang Liu; Zhen Qu; Yuexia Lv; Jingzhen Li; Yuwen Huang; Tao Jiang; Haibo Jia; Qing Wang; Jingyu Liu; Xinhua Shu; Zhaohui Tang; Mugen Liu
Journal:  Autophagy       Date:  2018-09-25       Impact factor: 16.016

View more
  1 in total

1.  Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results.

Authors:  Yoshinori Umezawa; Akihiko Asahina; Shinichi Imafuku; Yayoi Tada; Shigetoshi Sano; Akimichi Morita; Shinya Sakurai; Naoki Hoshii; Nicola Tilt; Hidemi Nakagawa
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.